Antidepressant effects of ketamine: mechanisms underlying fast-acting novel antidepressants.

作者: Caroline A. Browne , Irwin Lucki

DOI: 10.3389/FPHAR.2013.00161

关键词:

摘要: Newer antidepressants are needed for the many individuals with major depressive disorder that do not respond adequately to treatment and because of a delay weeks before emergence therapeutic effects. Recent evidence from clinical trials shows NMDA antagonist ketamine is revolutionary novel antidepressant it acts rapidly effective treatment-resistant patients. A single infusion alleviates symptoms in depressed patients within hours these effects may be sustained up 2 weeks. Although discovery ketamine’s has reshaped drug antidepressants, psychotomimetic properties this compound limit use therapy most severely ill In order develop additional like ketamine, adequate preclinical behavioral screening paradigms fast-acting need established used identify underlying neural mechanisms. This review examines literature attempting model antidepressant-like ketamine. Acute administration produced screens forced swim test, novelty suppression feeding rodent models depression. Protracted have been reported appear after last days. temporal pattern similar its serve as new animal paradigm rapid humans. addition, protracted changes molecules mediating synaptic plasticity implicated Current studies examining compounds more specific pharmacological at glutamate receptors synapses acting without hallucinogenic side or abuse potential

参考文章(123)
Betina Elfving, Tina Christensen, Cecilia Ratner, Jacob Wienecke, Anders B. Klein, Transient activation of mTOR following forced treadmill exercise in rats. Synapse. ,vol. 67, pp. 620- 625 ,(2013) , 10.1002/SYN.21668
Tamaki Hayase, Yoshiko Yamamoto, Keiichi Yamamoto, Behavioral effects of ketamine and toxic interactions with psychostimulants BMC Neuroscience. ,vol. 7, pp. 25- 25 ,(2006) , 10.1186/1471-2202-7-25
Felix Segmiller, Tobias Rüther, Andrea Linhardt, Frank Padberg, Michael Berger, Oliver Pogarell, Hans-Jürgen Möller, Christina Kohler, Cornelius Schüle, Repeated S‐ketamine Infusions in Therapy Resistant Depression: A Case Series The Journal of Clinical Pharmacology. ,vol. 53, pp. 996- 998 ,(2013) , 10.1002/JCPH.122
A. F. Carvalho, J. L. Cavalcante, M. S. Castelo, M. C. O. Lima, Augmentation strategies for treatment-resistant depression: a literature review. Journal of Clinical Pharmacy and Therapeutics. ,vol. 32, pp. 415- 428 ,(2007) , 10.1111/J.1365-2710.2007.00846.X
Janusz K. Rybakowski, Agnieszka Permoda-Osip, Maria Skibinska, Rafal Adamski, Alicja Bartkowska-Sniatkowska, Single ketamine infusion in bipolar depression resistant to antidepressants: are neurotrophins involved? Human Psychopharmacology-clinical and Experimental. ,vol. 28, pp. 87- 90 ,(2013) , 10.1002/HUP.2271
Ronald S. Duman, Nanxin Li, Rong-Jian Liu, Vanja Duric, George Aghajanian, Signaling pathways underlying the rapid antidepressant actions of ketamine. Neuropharmacology. ,vol. 62, pp. 35- 41 ,(2012) , 10.1016/J.NEUROPHARM.2011.08.044
Anita J. Bechtholt-Gompf, Karen L. Smith, Catherine S. John, Hannah H. Kang, William A. Carlezon, Bruce M. Cohen, Dost Öngür, CD-1 and Balb/cJ mice do not show enduring antidepressant-like effects of ketamine in tests of acute antidepressant efficacy. Psychopharmacology. ,vol. 215, pp. 689- 695 ,(2011) , 10.1007/S00213-011-2169-8
H. Homayoun, B. Moghaddam, NMDA Receptor Hypofunction Produces Opposite Effects on Prefrontal Cortex Interneurons and Pyramidal Neurons The Journal of Neuroscience. ,vol. 27, pp. 11496- 11500 ,(2007) , 10.1523/JNEUROSCI.2213-07.2007
Stefania Risso Bradley, Jason M. Uslaner, Rose B. Flick, Ariel Lee, Kristina M. Groover, Peter H. Hutson, The mGluR7 allosteric agonist AMN082 produces antidepressant-like effects by modulating glutamatergic signaling Pharmacology, Biochemistry and Behavior. ,vol. 101, pp. 35- 40 ,(2012) , 10.1016/J.PBB.2011.11.006
Nanxin Li, Rong-Jian Liu, Jason M. Dwyer, Mounira Banasr, Boyoung Lee, Hyeon Son, Xiao-Yuan Li, George Aghajanian, Ronald S. Duman, Glutamate N-methyl-D-aspartate receptor antagonists rapidly reverse behavioral and synaptic deficits caused by chronic stress exposure. Biological Psychiatry. ,vol. 69, pp. 754- 761 ,(2011) , 10.1016/J.BIOPSYCH.2010.12.015